Immune mechanisms in murine gammaherpesvirus-68 infection

Viral Immunology

Volumn 18, Issue 3, 2005, Pages 445-456

  Stevenson, Philip G ^a   Efstathiou, Stacey ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; VIRUS ANTIBODY;

CD8+ T LYMPHOCYTE; EPSTEIN BARR VIRUS; GENE AMPLIFICATION; GENE EXPRESSION; HERPES VIRUS; HERPES VIRUS INFECTION; HUMAN HERPESVIRUS 8; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IN VIVO STUDY; INFECTION CONTROL; INFECTIOUS MONONUCLEOSIS; MOUSE; MURINE GAMMA HERPESVIRUS 68; MURINE GAMMA HERPESVIRUS 68 INFECTION; NONHUMAN; PREDICTION; REVIEW; T LYMPHOCYTE; VACCINATION; VIRUS GENE; VIRUS IMMUNITY; VIRUS LATENCY; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; BIOLOGICAL MODEL; GENETICS; HUMAN; IMMUNOLOGY; PATHOGENICITY; VIROLOGY; VIRUS INFECTION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8; MURINAE; MURINE HEPATITIS VIRUS;

ANIMALS; ANTIBODIES, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; GAMMAHERPESVIRINAE; GENES, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; MICE; MODELS, BIOLOGICAL; T-LYMPHOCYTES; VACCINATION;

EID: 32944479900     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2005.18.445     Document Type: Review

References (115)

1. Bellows, D.S., B.N. Chau, P. Lee, Y. Lazebnik, W.H. Burns, and J.M. Hardwick. 2000. Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins. J Virol 74:5024-5031.
2. + T cells but confers minimal survival advantage on CD4-deficient mice. Proc Natl Acad Sci USA 97:2725-2730.
3. Bennett, N.J., J.S. May, and P.G. Stevenson. 2005. Gamma-herpesvirus latency requires T cell evasion during episome maintenance. PLoS Biol 3(4):e120.
4. Birkmann, A., K. Mahr, A. Ensser, S. Yaguboglu, F. Titgemeyer, B. Fleckenstein, and F. Neipel. 2001. Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1. J Virol 75:11583-11593.
5. Blasdell, K., C. McCracken, A. Morris, A.A. Nash, M. Begon, M. Bennett, and J.P. Stewart. 2003. The wood mouse is a natural host for Murid herpesvirus 4. J Gen Virol 84:111-113.
6. Blaskovic, D., M. Stancekova, J. Svobodova, and J. Mistrikova. 1980. Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol 24:468.
7. Boname, J.M., H.M. Coleman, J.S. May, and P.G. Stevenson. 2004. Protection against wild-type murine gamma-herpesvirus-68 latency by a latency-deficient mutant. J Gen Virol 85:131-135.
8. Boname, J.M., B.D. de Lima, P.J. Lehner, and P.G. Stevenson. 2004. Viral degradation of the MHC class I peptide loading complex. Immunity 20:305-317.
9. Boname, J.M., J.S. May, and P.G. Stevenson. 2005. The murine gamma-herpesvirus-68 MK3 protein causes TAP degradation independent of MHC class I heavy chain degradation. Eur J Immunol 35:171-179.
10. Boname, J.M., J.S. May, and P.G. Stevenson. 2005. Murine gammaherpesvirus 68 open reading frame 11 encodes a nonessential virion component. J Virol 79:3163-3168.
11. Boname, J.M., and P.G. Stevenson. 2001. MHC class I ubiquitination by a viral PHD/LAP finger protein. Immunity 15:627-636.
12. Bridgeman, A., P.G. Stevenson, J.P. Simas, and S. Efstathiou. 2001. A secreted chemokine binding protein encoded by murine gammaherpesvirus-68 is necessary for the establishment of a normal latent load. J Exp Med 194:301-312.
13. + T cells in acute infectious mononucleosis. Nat Med 2:906-911.
14. + T cells. J Exp Med 184:863-871.
15. + T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma. Proc Natl Acad Sci USA 96:5135-5140.
16. Clambey, E.T., H.W. Virgin, and S.H. Speck. 2000. Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency. J Virol 74:1973-1984.
17. Coleman, H.M., B. de Lima, V. Morton, and P.G. Stevenson. 2003. Murine gammaherpesvirus 68 lacking thymidine kinase shows severe attenuation of lytic cycle replication in vivo but still establishes latency. J Virol 77:2410-2417.
18. Coleman, H.M., S. Efstathiou, and P.G. Stevenson. 2005. Transcription of the murine gammaherpesvirus 68 ORF73 from promoters in the viral terminal repeats. J Gen Virol 86:561-574.
19. de Lima, B.D., J.S. May, S. Marques, J.P. Simas, and P.G. Stevenson. 2005. Murine gammaherpesvirus 68 bcl-2 homologue contributes to latency establishment in vivo. J Gen Virol 86:31-40.
20. de Lima, B.D., J.S. May, and P.G. Stevenson. 2004. Murine gammaherpesvirus 68 lacking gp150 shows defective virion release but establishes normal latency in vivo. J Virol 78:5103-5112.
21. Doherty, P.C., J.P. Christensen, G.T. Belz, P.G. Stevenson, and M.Y. Sangster. 2001. Dissecting the host response to a gamma-herpesvirus. Philos Trans R Soc Lond B Biol Sci 356:581-593.
22. Dutia, B.M., C.J. Clarke, D.J. Allen, and A.A. Nash. 1997. Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells. J Virol 71:4278-4283.
23. Efstathiou, S., Y.M. Ho, and A.C. Minson. 1990. Cloning and molecular characterization of the murine herpesvirus 68 genome. J Gen Virol 71:1355-1364.
24. Ehtisham, S., N.P. Sunil-Chandra, and A.A. Nash. 1993. Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J Virol 67:5247-5252.
25. Epstein, M.A., A.J. Morgan, S. Finerty, B.J. Randle, and J.K. Kirkwood. 1985. Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine. Nature 318:287-289.
26. Flano, E., I.J. Kim, D.L. Woodland, and M.A. Blackman. 2002. Gamma-herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J Exp Med 196:1363-1372.
27. Flano, E., D.L. Woodland, and M.A. Blackman. 2002. A mouse model for infectious mononucleosis. Immunol Res 25:201-217.
28. Fowler, P., and S. Efstathiou. 2004. Vaccine potential of a murine gammaherpesvirus-68 mutant deficient for ORF73. J Gen Virol 85:609-613.
29. Fowler, P., S. Marques, J.P. Simas, and S. Efstathiou. 2003. ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency. J Gen Virol 84:3405-3416.
30. Gangappa, S., S.B. Kapadia, S.H. Speck, and H.W. Virgin. 2002. Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice. J Virol 76:11460-11468.
31. Gangappa, S., L.F. van Dyk, T.J. Jewett, S.H. Speck, and H.W. Virgin. 2002. Identification of the in vivo role of a viral bcl-2. J Exp Med 195:931-940.
32. Grundhoff A., and D. Ganem. 2004. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 113:124-136.
33. + T cell responses from primary to persistent phases of Epstein-Barr virus infection. J Exp Med 195:893-905.
34. Hoge, A.T., S.B. Hendrickson, and W.H. Burns. 2000. Murine gammaherpesvirus 68 cyclin D homologue is required for efficient reactivation from latency. J Virol 74:7016-7023.
35. + T lymphocytes. Proc Natl Acad Sci USA 96:7508-7513.
36. Jacoby, M.A., H.W. Virgin, and S.H. Speck. 2002. Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation. J Virol 76:1790-1801.
37. + T lymphocytes. J Exp Med 169:1199-1212.
38. Kapadia, S.B., B. Levine, S.H. Speck, and H.W. Virgin. 2002. Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection. Immunity 17:143-155.
39. Kapadia, S.B., H. Molina, V. van Berkel, S.H. Speck, and H.W. Virgin. 1999. Murine gammaherpesvirus 68 encodes a functional regulator of complement activation. J Virol 73:7658-7670.
40. Koelle, D.M., J.M. Frank, M.L. Johnson, and W.W. Kwok. 1998. Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions. J Virol 72:7476-7483.
41. Laichalk, L.L., D. Hochberg, G.J. Babcock, R.B. Freeman, and D.A. Thorley-Lawson. 2002. The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity 16:745-754.
42. Lee, B.J., U.H. Koszinowski, S.R. Sarawar, and H. Adler. 2003. A gammaherpesvirus G protein-coupled receptor homologue is required for increased viral replication in response to chemokines and efficient reactivation from latency. J Immunol 170:243-251.
43. Levitskaya, J., M. Coram, V. Levitsky, S. Imreh, P.M. Steigerwald-Mullen, G. Klein, M.G. Kurilla, and M.G. Masucci. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685-688.
44. Liang, X., Y.C. Shin, R.E. Means, and J.U. Jung. 2004. Inhibition of interferon-mediated antiviral activity by murine gammaherpesvirus 68 latency-associated M2 protein. J Virol 78:12416-12427.
45. Lopes, F.B., S. Colaco, J.S. May, and P.G. Stevenson. 2004. Characterization of murine gammaherpesvirus 68 glycoprotein B. J Virol 78:13370-13375.
46. Lucin, P., I. Pavic, B. Polic, S. Jonjic, and U.H. Koszinowski. 1992. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J Virol 66:1977-1984.
47. Macrae, A.I., E.J. Usherwood, S.M. Husain, E. Flano, I.J. Kim, D.L. Woodland, A.A. Nash, M.A. Blackman, J.T. Sample, and J.P. Stewart. 2003. Murid herpesvirus 4 strain 68 M2 protein is a B-cell-associated antigen important for latency but not lymphocytosis. J Virol 77:9700-9709.
48. Macsween, K.F., and D.H. Crawford. 2003. Epstein-Barr virus-recent advances. Lancet Infect Dis 3:131-140.
49. Marques, S., S. Efstathiou, K.G. Smith, M. Haury, and J.P. Simas. 2003. Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes. J Virol 77:7308-7318.
50. May, J.S., S. Colaco, and P.G. Stevenson. 2005. Glycoprotein M is an essential lytic replication protein of the murine gamma-herpesvirus-68. J Virol 79:3459-3468.
51. May, J.S., H.M. Coleman, J.M. Boname, and P.G. Stevenson. 2005. The murine gamma-herpesvirus-68 ORF28 encodes a non-essential virion glycoprotein. J Gen Virol 86:919-928.
52. May, J.S., H.M. Coleman, B. Smillie, S. Efstathiou, and P.G. Stevenson. 2004. Forced lytic replication impairs host colonization by a latency-deficient mutant of murine gammaherpesvirus-68. J Gen Virol 85:137-146.
53. May, J.S., J. Walker, S. Colaco, and P.G. Stevenson. 2005. The murine gammaherpesvirus-68 ORF27 gene product contributes to intercellular viral spread. J Virol 79:5059-5068.
54. McGeoch, D.J. 2001. Molecular evolution of the gammaherpesvirinae. Philos Trans R Soc Lond B Biol Sci 356:421-435.
55. Moore, P.S., and Y. Chang. 2003. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annu Rev Microbiol 57:609-639.
56. Moorman, N.J., C.Y. Lin, and S.H. Speck. 2004. Identification of candidate gammaherpesvirus 68 genes required for virus replication by signature-tagged transposon mutagenesis. J Virol 78:10282-10290.
57. Moorman, N.J., H.W. Virgin, and S.H. Speck. 2003. Disruption of the gene encoding the gammaHV68 v-GPCR leads to decreased efficiency of reactivation from latency. Virology 307:179-190.
58. Moorman, N.J., D.O. Willer, and S.H. Speck. 2003. The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency. J Virol 77:10295-10303.
59. Nash, A.A., and N.P. Sunil-Chandra. 1994. Interactions of the murine gammaherpesvirus with the immune system. Curr Opin Immunol 6:560-563.
60. +-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferation. J Virol 77:12088-12104.
61. Parry, C.M., J.P. Simas, V.P. Smith, C.A. Stewart, A.C. Minson, S. Efstathiou, and A. Alcami. 2000. A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med 191:573-578.
62. Pavlova, I.V., H.W. Virgin, and S.H. Speck. 2003. Disruption of gammaherpesvirus 68 gene 50 demonstrates that Rta is essential for virus replication. J Virol 77:5731-5739.
63. Pegtel, D.M., J. Middeldorp, and D.A. Thorley-Lawson. 2004. Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers. J Virol 78:12613-12624.
64. Pepper, S.D., J.P. Stewart, J.R. Arrand, and M. Mackett. 1996. Murine gammaherpesvirus-68 encodes homologues of thymidine kinase and glycoprotein H: sequence, expression, and characterization of pyrimidine kinase activity. Virology 219:475-479.
65. Polic, B., S. Jonjic, I. Pavic, I. Crnkovic, I. Zorica, H. Hengel, P. Lucin, and U.H. Koszinowski. 1996. Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo. J Gen Virol 77:217-225.
66. Presti, R.M., J.L. Pollock, A.J. Dal Canto, A.K. O'Guin, and H.W. Virgin. 1998. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med 188:577-588.
67. Raftery, M.J., M. Schwab, S.M. Eibert, Y. Samstag, H. Walczak, and G. Schonrich. 2001. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 15:997-1009.
68. Raslova, H., M. Berebbi, J. Rajcani, A. Sarasin, J. Matis, and M. Kudelova. 2001. Susceptibility of mouse mammary glands to murine gammaherpesvirus 72 (MHV-72) infection: evidence of MHV-72 transmission via breast milk. Microb Pathog 31:47-58.
69. Rice, J., B. de Lima, F.K. Stevenson, and P.G. Stevenson. 2002. A gamma-herpesvirus immune evasion gene allows tumor cells in vivo to escape attack by cytotoxic T cells specific for a tumor epitope. Eur J Immunol 32:3481-3487.
70. Rickinson, A. 2002. Epstein-Barr virus. Virus Res 82: 109-113.
71. Rickinson, A.B., Q.Y. Yao, and L.E. Wallace. 1985. The Epstein-Barr virus as a model of virus-host interactions. Br Med Bull 41:75-79.
72. Rooney, C.M., L.K. Aguilar, M.H. Huls, M.K. Brenner, and H.E. Heslop. 2001. Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T-cell lines. Curr Top Microbiol Immunol 258:221-229.
73. Roy, D.J., B.C. Ebrahimi, B.M. Dutia, A.A. Nash, and J.P. Stewart. 2000. Murine gammaherpesvirus M11 gene product inhibits apoptosis and is expressed during virus persistence. Arch Virol 145:2411-2420.
74. Salio, M., M. Cella, M. Suter, and A. Lanzavecchia. 1999. Inhibition of dendritic cell maturation by herpes simplex virus. Eur J Immunol 29:3245-3253.
75. Sangster, M.Y., D.J. Topham, S. D'Costa, R.D. Cardin, T.N. Marion, L.K. Myers, and P.C. Doherty. 2000. Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J Immunol 164:1820-1828.
76. Simas, J.P., and S. Efstathiou. 1998. Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. Trends Microbiol 6:276-282.
77. Simas, J.P., S. Marques, A. Bridgeman, S. Efstathiou, and H. Adler. 2004. The M2 gene product of murine gammaherpesvirus 68 is required for efficient colonization of splenic follicles but is not necessary for expansion of latently infected germinal centre B cells. J Gen Virol 85:2789-2797.
78. Simmons, A., and D.C. Tscharke. 1992. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J Exp Med 175:1337-1344.
79. Speck, S.H., and H.W. Virgin. 1999. Host and viral genetics of chronic infection: a mouse model of gamma-herpesvirus pathogenesis. Curr Opin Microbiol 2:403-409.
80. Stevenson, P.G. 2004. Immune evasion by gamma-herpes viruses. Curr Opin Immunol 16:456-462.
81. + T cell response during acute and persistent murine gamma-herpesvirus infection. Eur J Immunol 29:1059-1067.
82. + T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice. Proc Natl Acad Sci USA 95:15565-15570.
83. + T cell response primed to a lytic-phase epitope. Proc Natl Acad Sci USA 96:9281-9286.
84. Stevenson, P.G., J.M. Boname, B. de Lima, and S. Efstathiou. 2002. A battle for survival: immune control and immune evasion in murine gamma-herpesvirus-68 infection. Microbes Infect 4:1177-1182.
85. + T cells. J Gen Virol 80:477-483.
86. Stevenson, P.G., and P.C. Doherty. 1999. Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. J Virol 73:1075-1079.
87. + T cells aids amplification of a latent gamma-herpesvirus. Nat Immunol 3:733-740.
88. Stewart, J.P., N.J. Janjua, S.D. Pepper, G. Bennion, M. Mackett, T. Allen, A.A. Nash, and J.R. Arrand. 1996. Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein. J Virol 70:3528-3535.
89. Stewart, J.P., N. Micali, E.J. Usherwood, L. Bonina, and A.A. Nash. 1999. Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination. Vaccine 17:152-157.
90. Stewart, J.P., E.J. Usherwood, A. Ross, H. Dyson, and T. Nash. 1998. Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J Exp Med 187: 1941-1951.
91. Sunil-Chandra, N.P., S. Efstathiou, J. Arno, and A.A. Nash. 1992. Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J Gen Virol 73:2347-2356.
92. Tanner, J., J. Weis, D. Fearon, Y. Whang, and E. Kieff. 1987. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 50:203-213.
93. Thorley-Lawson, D.A. 2001. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 1:75-82.
94. Thorley-Lawson, D.A., and K. Geilinger. 1980. Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity. Proc Natl Acad Sci USA 77:5307-5311.
95. Tibbetts, S.A., L.F. van Dyk, S.H. Speck, and H.W. Virgin. 2002. Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus. J Virol 76:7125-7132.
96. Tomazin, R., N.B. van Schoot, K. Goldsmith, P. Jugovic, P. Sempe, K. Fruh, and D.C. Johnson. 1998. Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. J Virol 72:2560-2563.
97. Tripp, R.A., A.M. Hamilton-Easton, R.D. Cardin, P. Nguyen, F.G. Behm, D.L. Woodland, P.C. Doherty, and M.A. Blackman. 1997. Pathogenesis of an infectious mononucleosis-like disease induced by a murine gammaherpesvirus: role for a viral superantigen? J Exp Med 185:1641-1650.
98. Usherwood, E.J., J.W. Brooks, S.R. Sarawar, R.D. Cardin, W.D. Young, D.J. Allen, P.C. Doherty, and A.A. Nash. 1997. Immunological control of murine gammaherpesvirus infection is independent of perform. J Gen Virol 78:2025-2030.
99. Usherwood, E.J., A.J. Ross, D.J. Allen, and A.A. Nash. 1996. Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells. J Gen Virol 77:627-630.
100. + T cells. J Exp Med 192:943-952.
101. Usherwood, E.J., J.P. Stewart, K. Robertson, D.J. Allen, and A.A. Nash. 1996. Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J Gen Virol 77:2819-2825.
102. Usherwood, E.J., K.A. Ward, M.A. Blackman, J.P. Stewart, and D.L. Woodland. 2001. Latent antigen vaccination in a model gammaherpesvirus infection. J Virol 75:8283-8288.
103. van Berkel, V., B. Levine, S.B. Kapadia, J.E. Goldman, S.H. Speck, and H.W. Virgin. 2002. Critical role for a high-affinity chemokine-binding protein in gammaherpesvirus-induced lethal meningitis. J Clin Invest 109:905-914.
104. Virgin, H.W. P. Latreille, P. Wamsley, K. Hallsworth, K.E. Weck, A.J. Dal Canto, and S.H. Speck. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71:5894-5904.
105. Wang, F.Z., S.M. Akula, N.P. Pramod, L. Zeng, and B. Chandran. 2001. Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate. J Virol 75:7517-7527.
106. Wang, G.H., T.L. Garvey, and J.I. Cohen. 1999. The murine gammaherpesvirus-68 M11 protein inhibits Fas- and TNF-induced apoptosis. J Gen Virol 80:2737-2740.
107. Weck, K.E., M.L. Barkon, L.I. Yoo, S.H. Speck, and H.I. Virgin. 1996. Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J Virol 70:6775-6780.
108. Weck, K.E., A.J. Dal Canto, J.D. Gould, A.K. O'Guin, K.A. Roth, J.E. Saffitz, S.H. Speck, and H.W. Virgin. 1997. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nat Med 3:1346-1353.
109. Willer, D.O., and S.H. Speck. 2003. Long-term latent murine Gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo. J Virol 77:8310-8321.
110. Wu, T.T., E.J. Usherwood, J.P. Stewart, A.A. Nash, and R. Sun. 2000. Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency. J Virol 74:3659-3667.
111. Yao, Q.Y., A.B. Rickinson, and M.A. Epstein. 1985. A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer 35:35-42.
112. Yao, Q.Y., M. Rowe, A.J. Morgan, C.K. Sam, U. Prasad, H. Dang, Y. Zeng, and A.B. Rickinson. 1991. Salivary and serum IgA antibodies to the Epstein-Barr virus glycoprotein gp340: incidence and potential for virus neutralization. Int J Cancer 48:45-50.
113. Yao, Q.Y., R.J. Tierney, D. Croom-Carter, D. Dukers, G.M. Cooper, C.J. Ellis, M. Rowe, and A.B. Rickinson. 1996. Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals. J Virol 70:4884-4894.
114. Young, L.S., and A.B. Rickinson. 2004. Epstein-Barr virus: 40 years on. Nat Rev Cancer 4:757-768.
115. 2-microglobulin assembly. J Virol 76:2796-2803.